113 related articles for article (PubMed ID: 32720497)
1. Identification of an immune-related key gene, PPARGC1A, in the development of anaplastic thyroid carcinoma: in-silico study and in-vitro evaluation.
Huang Y; Ling J; Chang A; Ye H; Zhao H; Zhuo X
Minerva Endocrinol (Torino); 2022 Jun; 47(2):150-159. PubMed ID: 32720497
[TBL] [Abstract][Full Text] [Related]
2. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
Hu S; Liao Y; Chen L
Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
[TBL] [Abstract][Full Text] [Related]
3. Identification of Hub Genes in Anaplastic Thyroid Carcinoma: Evidence From Bioinformatics Analysis.
Li L; Zhu M; Huang H; Wu J; Meng D
Technol Cancer Res Treat; 2020; 19():1533033820962135. PubMed ID: 33025856
[TBL] [Abstract][Full Text] [Related]
4. Genes and pathways identified in thyroid carcinoma based on bioinformatics analysis.
Yu JW; Mai W; Cui YL; Kong LY
Neoplasma; 2016; 63(4):559-68. PubMed ID: 27268919
[TBL] [Abstract][Full Text] [Related]
5. Integrated Bioinformatics Analysis of Master Regulators in Anaplastic Thyroid Carcinoma.
Pan Z; Li L; Fang Q; Qian Y; Zhang Y; Zhu J; Ge M; Huang P
Biomed Res Int; 2019; 2019():9734576. PubMed ID: 31183379
[TBL] [Abstract][Full Text] [Related]
6. TMEM158 May Serve as a Diagnostic Biomarker for Anaplastic Thyroid Carcinoma: An Integrated Bioinformatic Analysis.
Li HN; Du YY; Xu T; Zhang R; Wang G; Lv ZT; Li XR
Curr Med Sci; 2020 Dec; 40(6):1137-1147. PubMed ID: 33428142
[TBL] [Abstract][Full Text] [Related]
7. Cell Cycle M-Phase Genes Are Highly Upregulated in Anaplastic Thyroid Carcinoma.
Weinberger P; Ponny SR; Xu H; Bai S; Smallridge R; Copland J; Sharma A
Thyroid; 2017 Feb; 27(2):236-252. PubMed ID: 27796151
[TBL] [Abstract][Full Text] [Related]
8. Recognition of Key Genes in Human Anaplastic Thyroid Cancer via the Weighing Gene Coexpression Network.
Gong Y; Xu F; Deng L; Peng L
Biomed Res Int; 2022; 2022():2244228. PubMed ID: 35782055
[TBL] [Abstract][Full Text] [Related]
9. Key genes and pathways predicted in papillary thyroid carcinoma based on bioinformatics analysis.
Yu J; Mai W; Cui Y; Kong L
J Endocrinol Invest; 2016 Nov; 39(11):1285-1293. PubMed ID: 27250077
[TBL] [Abstract][Full Text] [Related]
10. Identification of key candidate genes and pathways in anaplastic thyroid cancer by bioinformatics analysis.
Ding YG; Ren YL; Xu YS; Wei CS; Zhang YB; Zhang SK; Guo CA
Am J Otolaryngol; 2020; 41(3):102434. PubMed ID: 32093976
[TBL] [Abstract][Full Text] [Related]
11. Integrated analysis of transcriptome data revealed MMP3 and MMP13 as critical genes in anaplastic thyroid cancer progression.
Ma Y; Cang S; Li G; Su Y; Zhang H; Wang L; Yang J; Shi X; Qin G; Yuan H
J Cell Physiol; 2019 Dec; 234(12):22260-22271. PubMed ID: 31081124
[TBL] [Abstract][Full Text] [Related]
12. A signature of circadian rhythm genes in driving anaplastic thyroid carcinoma malignant progression.
Xu T; Jin T; Lu X; Pan Z; Tan Z; Zheng C; Liu Y; Hu X; Ba L; Ren H; Chen J; Zhu C; Ge M; Huang P
Cell Signal; 2022 Jul; 95():110332. PubMed ID: 35430345
[TBL] [Abstract][Full Text] [Related]
13. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
14. Identification of key pathways and biomarkers in anaplastic thyroid cancer using an integrated analysis.
Zhou J; Dong S; Shi C
J BUON; 2020; 25(6):2690-2699. PubMed ID: 33455115
[TBL] [Abstract][Full Text] [Related]
15. Elucidation of the molecular mechanisms of anaplastic thyroid carcinoma by integrated miRNA and mRNA analysis.
Liu G; Wu K; Sheng Y
Oncol Rep; 2016 Nov; 36(5):3005-3013. PubMed ID: 27599582
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel characteristic biomarkers and immune infiltration profile for the anaplastic thyroid cancer via machine learning algorithms.
Li C; Dong X; Yuan Q; Xu G; Di Z; Yang Y; Hou J; Zheng L; Chen W; Wu G
J Endocrinol Invest; 2023 Aug; 46(8):1633-1650. PubMed ID: 36725810
[TBL] [Abstract][Full Text] [Related]
17. Key genes involved in cell cycle arrest and DNA damage repair identified in anaplastic thyroid carcinoma using integrated bioinformatics analysis.
Zhang Z; Zou Z; Dai H; Ye R; Di X; Li R; Ha Y; Sun Y; Gan S
Transl Cancer Res; 2020 Jul; 9(7):4188-4203. PubMed ID: 35117787
[TBL] [Abstract][Full Text] [Related]
18. IL2RA
Pan Z; Bao L; Lu X; Hu X; Li L; Chen J; Jin T; Zhang Y; Tan Z; Huang P; Ge M
Biochim Biophys Acta Mol Basis Dis; 2023 Jan; 1869(1):166591. PubMed ID: 36328145
[TBL] [Abstract][Full Text] [Related]
19. Weighted gene co-expression network reveals driver genes contributing to phenotypes of anaplastic thyroid carcinoma and immune checkpoint identification for therapeutic targets.
Dong X; Yang Y; Hou J; Chen W; Yuan Q; Xu G; Liu J; Li C; Wu G
Front Oncol; 2022; 12():1018479. PubMed ID: 36530988
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics analysis of key genes and latent pathway interactions based on the anaplastic thyroid carcinoma gene expression profile.
Huang Y; Tao Y; Li X; Chang S; Jiang B; Li F; Wang ZM
Oncol Lett; 2017 Jan; 13(1):167-176. PubMed ID: 28428828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]